Vesal, M.; Moazen Safaei, Y.; Ramazi, S.; Allahverdi, A.; Abdolmaleki, P.; Naderi-Manesh, H.
Enhanced Antiproliferative Activity of Docetaxel by Extremely Low Frequency Electromagnetic Fields in MCF-7 Breast Cancer Cells. Pharmaceutics 2025, 17, 1505.
https://doi.org/10.3390/pharmaceutics17121505
AMA Style
Vesal M, Moazen Safaei Y, Ramazi S, Allahverdi A, Abdolmaleki P, Naderi-Manesh H.
Enhanced Antiproliferative Activity of Docetaxel by Extremely Low Frequency Electromagnetic Fields in MCF-7 Breast Cancer Cells. Pharmaceutics. 2025; 17(12):1505.
https://doi.org/10.3390/pharmaceutics17121505
Chicago/Turabian Style
Vesal, Maryam, Yasaman Moazen Safaei, Shahin Ramazi, Abdollah Allahverdi, Parviz Abdolmaleki, and Hossein Naderi-Manesh.
2025. "Enhanced Antiproliferative Activity of Docetaxel by Extremely Low Frequency Electromagnetic Fields in MCF-7 Breast Cancer Cells" Pharmaceutics 17, no. 12: 1505.
https://doi.org/10.3390/pharmaceutics17121505
APA Style
Vesal, M., Moazen Safaei, Y., Ramazi, S., Allahverdi, A., Abdolmaleki, P., & Naderi-Manesh, H.
(2025). Enhanced Antiproliferative Activity of Docetaxel by Extremely Low Frequency Electromagnetic Fields in MCF-7 Breast Cancer Cells. Pharmaceutics, 17(12), 1505.
https://doi.org/10.3390/pharmaceutics17121505